Treatment With Azacitidine of Recurrent Gliomas With IDH1/2 Mutation
Clinical trial NCT03666559 · UNKNOWN
Trial details
- NCT number
- NCT03666559
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-22
- Primary completion
- 2023-02-23
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.